These results demonstrated that an anti-HER2 affinity higher than a certain threshold (KD ≈ 130 nM) is required; thus, the affinity of KD ≈ 217 nM is too low for selective tumor targeting and retention of HCT-mono-mIL12 in CT25-HER2/neu tumors. Here, ERBB2 is linked to neoplasm.